{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T16:58:24Z","timestamp":1794070704657,"version":"4.8.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"DOI":"10.1038\/s43856-025-00987-4","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T08:39:46Z","timestamp":1752136786000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Machine learning approaches to dissect hybrid and vaccine-induced immunity"],"prefix":"10.1038","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9054-2756","authenticated-orcid":false,"given":"Giorgio","family":"Montesi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7102-2724","authenticated-orcid":false,"given":"Simone","family":"Costagli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3545-7433","authenticated-orcid":false,"given":"Simone","family":"Lucchesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8345-0546","authenticated-orcid":false,"given":"Jacopo","family":"Polvere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1440-8061","authenticated-orcid":false,"given":"Fabio","family":"Fiorino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabiria","family":"Pastore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Sambo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Tumbarello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Fabbiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2267-1337","authenticated-orcid":false,"given":"Francesca","family":"Montagnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1729-7325","authenticated-orcid":false,"given":"Donata","family":"Medaglini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Pettini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4585-7783","authenticated-orcid":false,"given":"Annalisa","family":"Ciabattini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,8]]},"reference":[{"key":"987_CR1","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/j.immuni.2021.08.001","volume":"54","author":"MM Painter","year":"2021","unstructured":"Painter, M. M. et al. Rapid induction of antigen-specific CD4+ T cells is associated with coordinated humoral and cellular immunity to SARS-CoV-2 mRNA vaccination. Immunity 54, 2133\u20132142.e3 (2021).","journal-title":"Immunity"},{"key":"987_CR2","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/s41586-021-03738-2","volume":"596","author":"JS Turner","year":"2021","unstructured":"Turner, J. S. et al. SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses. Nature 596, 109\u2013113 (2021).","journal-title":"Nature"},{"key":"987_CR3","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","volume":"384","author":"LR Baden","year":"2021","unstructured":"Baden, L. R. et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 Vaccine. N. Engl. J. Med. 384, 403\u2013416 (2021).","journal-title":"N. Engl. J. Med."},{"key":"987_CR4","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/s41586-021-03324-6","volume":"592","author":"Z Wang","year":"2021","unstructured":"Wang, Z. et al. mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants. Nature 592, 616\u2013622 (2021).","journal-title":"Nature"},{"key":"987_CR5","unstructured":"Interim statement on hybrid immunity and increasing population seroprevalence rates. https:\/\/www.who.int\/news\/item\/01-06-2022-interim-statement-on-hybrid-immunity-and-increasing-population-seroprevalence-rates#."},{"key":"987_CR6","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1093\/infdis\/jiad353","volume":"228","author":"N Lasrado","year":"2023","unstructured":"Lasrado, N. & Barouch, D. H. SARS-CoV-2 hybrid immunity: the best of both Worlds. J. Infect. Dis. 228, 1311\u20131313 (2023).","journal-title":"J. Infect. Dis."},{"key":"987_CR7","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1016\/S1473-3099(22)00746-0","volume":"22","author":"The Lancet Infectious Diseases, null.","year":"2022","unstructured":"The Lancet Infectious Diseases, null. Why hybrid immunity is so triggering. Lancet Infect. Dis. 22, 1649 (2022).","journal-title":"Lancet Infect. Dis."},{"key":"987_CR8","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1126\/science.abn7591","volume":"375","author":"A Muik","year":"2022","unstructured":"Muik, A. et al. Neutralization of SARS-CoV-2 Omicron by BNT162b2 mRNA vaccine-elicited human sera. Science 375, 678\u2013680 (2022).","journal-title":"Science"},{"key":"987_CR9","doi-asserted-by":"publisher","first-page":"104765","DOI":"10.1016\/j.jcv.2021.104765","volume":"136","author":"J Van Elslande","year":"2021","unstructured":"Van Elslande, J. et al. Longitudinal follow-up of IgG anti-nucleocapsid antibodies in SARS-CoV-2 infected patients up to eight months after infection. J. Clin. Virol. 136, 104765 (2021).","journal-title":"J. Clin. Virol."},{"key":"987_CR10","doi-asserted-by":"publisher","first-page":"5790","DOI":"10.1002\/jmv.28066","volume":"94","author":"W Yu","year":"2022","unstructured":"Yu, W. et al. Proportion of asymptomatic infection and nonsevere disease caused by SARS\u2010CoV\u20102 Omicron variant: A systematic review and analysis. J. Med. Virol. 94, 5790\u20135801 (2022).","journal-title":"J. Med. Virol."},{"key":"987_CR11","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.3390\/v13061115","volume":"13","author":"Z Bai","year":"2021","unstructured":"Bai, Z., Cao, Y., Liu, W. & Li, J. The SARS-CoV-2 nucleocapsid protein and its role in viral structure, biological functions, and a potential target for drug or vaccine mitigation. Viruses 13, 1115 (2021).","journal-title":"Viruses"},{"key":"987_CR12","doi-asserted-by":"publisher","first-page":"115659","DOI":"10.1016\/j.diagmicrobio.2022.115659","volume":"103","author":"J Van Elslande","year":"2022","unstructured":"Van Elslande, J. et al. Lower persistence of anti-nucleocapsid compared to anti-spike antibodies up to one year after SARS-CoV-2 infection. Diagn. Microbiol. Infect. Dis. 103, 115659 (2022).","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"987_CR13","doi-asserted-by":"publisher","first-page":"3202","DOI":"10.1002\/eji.202149535","volume":"51","author":"A Haveri","year":"2021","unstructured":"Haveri, A. et al. Persistence of neutralizing antibodies a year after SARS-CoV-2 infection in humans. Eur. J. Immunol. 51, 3202\u20133213 (2021).","journal-title":"Eur. J. Immunol."},{"key":"987_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103561","volume":"71","author":"F Gallais","year":"2021","unstructured":"Gallais, F. et al. Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection. EBioMedicine 71, 103561 (2021).","journal-title":"EBioMedicine"},{"key":"987_CR15","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.trsl.2021.02.006","volume":"232","author":"C Doba\u00f1o","year":"2021","unstructured":"Doba\u00f1o, C. et al. Immunogenicity and crossreactivity of antibodies to the nucleocapsid protein of SARS-CoV-2: utility and limitations in seroprevalence and immunity studies. Transl. Res. 232, 60\u201374 (2021).","journal-title":"Transl. Res."},{"key":"987_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28898-1","volume":"13","author":"A Tomic","year":"2022","unstructured":"Tomic, A. et al. Divergent trajectories of antiviral memory after SARS-CoV-2 infection. Nat. Commun. 13, 1251 (2022).","journal-title":"Nat. Commun."},{"key":"987_CR17","doi-asserted-by":"publisher","first-page":"1158905","DOI":"10.3389\/fimmu.2023.1158905","volume":"14","author":"R Marcinkevics","year":"2023","unstructured":"Marcinkevics, R. et al. Machine learning analysis of humoral and cellular responses to SARS-CoV-2 infection in young adults. Front. Immunol. 14, 1158905 (2023).","journal-title":"Front. Immunol."},{"key":"987_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05147-1","volume":"22","author":"G Montesi","year":"2024","unstructured":"Montesi, G. et al. Predicting humoral responses to primary and booster SARS-CoV-2 mRNA vaccination in people living with HIV: a machine learning approach. J. Transl. Med. 22, 432 (2024).","journal-title":"J. Transl. Med."},{"key":"987_CR19","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.ajt.2024.11.033","volume":"25","author":"G Azarfar","year":"2025","unstructured":"Azarfar, G. et al. Using machine learning for personalized prediction of longitudinal coronavirus disease 2019 vaccine responses in transplant recipients. Am. J. Transplant. 25, 1107\u20131116 (2025).","journal-title":"Am. J. Transplant."},{"key":"987_CR20","doi-asserted-by":"publisher","first-page":"1062136","DOI":"10.3389\/fimmu.2022.1062136","volume":"13","author":"A Konnova","year":"2022","unstructured":"Konnova, A. et al. Predictive model for BNT162b2 vaccine response in cancer patients based on blood cytokines and growth factors. Front. Immunol. 13, 1062136 (2022).","journal-title":"Front. Immunol."},{"key":"987_CR21","doi-asserted-by":"publisher","first-page":"740708","DOI":"10.3389\/fimmu.2021.740708","volume":"12","author":"A Ciabattini","year":"2021","unstructured":"Ciabattini, A. et al. Evidence of SARS-CoV-2-Specific Memory B cells six months after vaccination with the BNT162b2 mRNA Vaccine. Front. Immunol. 12, 740708 (2021).","journal-title":"Front. Immunol."},{"key":"987_CR22","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s43856-023-00245-5","volume":"3","author":"J Polvere","year":"2023","unstructured":"Polvere, J. et al. B cell response after SARS-CoV-2 mRNA vaccination in people living with HIV. Commun. Med. 3, 13 (2023).","journal-title":"Commun. Med."},{"key":"987_CR23","doi-asserted-by":"crossref","unstructured":"McInnes, L., Healy, J., Saul, N. & Gro\u00dfberger, L. UMAP: Uniform Manifold Approximation and Projection. J. Open Source Softw. 3, 861 (2018).","DOI":"10.21105\/joss.00861"},{"key":"987_CR24","unstructured":"Maaten, L. van der & Hinton, G. Visualizing Data using t-SNE. J. Mach. Learn. Res. 9, 2579\u20132605 (2008)."},{"key":"987_CR25","doi-asserted-by":"crossref","unstructured":"Scrucca, L., Fraley, C., Murphy, T. B. & Raftery, A. E. Model-Based Clustering, Classification, and Density Estimation Using Mclust in R (CRC Press, 2023).","DOI":"10.1201\/9781003277965"},{"key":"987_CR26","unstructured":"Hennig, C. fpc: Flexible Procedures for Clustering. R package version 2.2-13, https:\/\/CRAN.R-project.org\/package=fpc (2024)."},{"key":"987_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v028.i05","volume":"28","author":"M Kuhn","year":"2008","unstructured":"Kuhn, M. Building predictive models in R Using the caret Package. J. Stat. Softw. 28, 1\u201326 (2008).","journal-title":"J. Stat. Softw."},{"key":"987_CR28","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.3390\/cells12131706","volume":"12","author":"A Ciabattini","year":"2023","unstructured":"Ciabattini, A. et al. Trajectory of spike-specific B cells elicited by two doses of BNT162b2 mRNA vaccine. Cells 12, 1706 (2023).","journal-title":"Cells"},{"key":"987_CR29","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1002\/cyto.a.22625","volume":"87","author":"S Van Gassen","year":"2015","unstructured":"Van Gassen, S. et al. FlowSOM: using self\u2010organizing maps for visualization and interpretation of cytometry data. Cytometry A 87, 636\u2013645 (2015).","journal-title":"Cytometry A"},{"key":"987_CR30","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1093\/bioinformatics\/btu677","volume":"31","author":"M Malek","year":"2015","unstructured":"Malek, M. et al. flowDensity: reproducing manual gating of flow cytometry data by automated density-based cell population identification. Bioinforma. Oxf. Engl. 31, 606\u2013607 (2015).","journal-title":"Bioinforma. Oxf. Engl."},{"key":"987_CR31","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/s41586-022-04462-1","volume":"603","author":"R Suzuki","year":"2022","unstructured":"Suzuki, R. et al. Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant. Nature 603, 700\u2013705 (2022).","journal-title":"Nature"},{"key":"987_CR32","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1080\/14760584.2024.2333952","volume":"23","author":"G Pastore","year":"2024","unstructured":"Pastore, G. et al. Homologous or heterologous administration of mRNA or adenovirus-vectored vaccines show comparable immunogenicity and effectiveness against the SARS-CoV-2 Omicron variant. Expert Rev. Vaccines 23, 432\u2013444 (2024).","journal-title":"Expert Rev. Vaccines"},{"key":"987_CR33","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1056\/NEJMc2119912","volume":"386","author":"R Pajon","year":"2022","unstructured":"Pajon, R. et al. SARS-CoV-2 omicron variant neutralization after mRNA-1273 booster vaccination. N. Engl. J. Med. 386, 1088\u20131091 (2022).","journal-title":"N. Engl. J. Med."},{"key":"987_CR34","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41591-021-01676-0","volume":"28","author":"H Gruell","year":"2022","unstructured":"Gruell, H. et al. mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant. Nat. Med. 28, 477\u2013480 (2022).","journal-title":"Nat. Med."},{"key":"987_CR35","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.3390\/vaccines10071049","volume":"10","author":"W Shang","year":"2022","unstructured":"Shang, W. et al. Percentage of asymptomatic Infections among SARS-CoV-2 omicron variant-positive individuals: a systematic review and meta-analysis. Vaccines 10, 1049 (2022).","journal-title":"Vaccines"},{"key":"987_CR36","doi-asserted-by":"publisher","DOI":"10.1111\/irv.13348","volume":"18","author":"NDJ Shi","year":"2024","unstructured":"Shi, N. D. J. et al. The asymptomatic proportion of SARS-CoV-2 omicron variant infections in households: a systematic review. Influenza Other Respir. Viruses 18, e13348 (2024).","journal-title":"Influenza Other Respir. Viruses"},{"key":"987_CR37","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.4049\/jimmunol.1801236","volume":"203","author":"J Fraussen","year":"2019","unstructured":"Fraussen, J. et al. Phenotypic and Ig repertoire analyses indicate a common origin of IgD-CD27- Double Negative B cells in healthy individuals and multiple sclerosis patients. J. Immunol. 203, 1650\u20131664 (2019).","journal-title":"J. Immunol."},{"key":"987_CR38","doi-asserted-by":"publisher","first-page":"6624","DOI":"10.4049\/jimmunol.178.10.6624","volume":"178","author":"C Wei","year":"2007","unstructured":"Wei, C. et al. A new population of cells lacking expression of CD27 represents a notable component of the B cell memory compartment in systemic lupus erythematosus. J. Immunol. 178, 6624\u20136633 (2007).","journal-title":"J. Immunol."},{"key":"987_CR39","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.mad.2009.08.003","volume":"130","author":"G Colonna-Romano","year":"2009","unstructured":"Colonna-Romano, G. et al. A double-negative (IgD-CD27-) B cell population is increased in the peripheral blood of elderly people. Mech. Ageing Dev. 130, 681\u2013690 (2009).","journal-title":"Mech. Ageing Dev."},{"key":"987_CR40","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3389\/fimmu.2011.00081","volume":"2","author":"Y-CB Wu","year":"2011","unstructured":"Wu, Y.-C. B., Kipling, D. & Dunn-Walters, D. K. The relationship between CD27 negative and positive B cell populations in human peripheral blood. Front. Immunol. 2, 81 (2011).","journal-title":"Front. Immunol."},{"key":"987_CR41","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.imlet.2023.03.003","volume":"255","author":"L Beckers","year":"2023","unstructured":"Beckers, L., Somers, V. & Fraussen, J. IgD\u2212CD27\u2212 double negative (DN) B cells: origins and functions in health and disease. Immunol. Lett. 255, 67\u201376 (2023).","journal-title":"Immunol. Lett."},{"key":"987_CR42","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.exger.2016.12.001","volume":"87","author":"D Frasca","year":"2017","unstructured":"Frasca, D., Diaz, A., Romero, M. & Blomberg, B. B. Human peripheral late\/exhausted memory B cells express a senescent-associated secretory phenotype and preferentially utilize metabolic signaling pathways. Exp. Gerontol. 87, 113\u2013120 (2017).","journal-title":"Exp. Gerontol."},{"key":"987_CR43","doi-asserted-by":"publisher","unstructured":"Montesi, G. et al. Machine learning approaches to dissect hybrid and vaccine-induced immunity dataset. Zenodo, https:\/\/doi.org\/10.5281\/zenodo.15518709 (2025).","DOI":"10.5281\/zenodo.15518709"},{"key":"987_CR44","doi-asserted-by":"publisher","unstructured":"Giomu. Giomu\/ML_ADHVII. Zenodo, https:\/\/doi.org\/10.5281\/zenodo.15496792 (2025).","DOI":"10.5281\/zenodo.15496792"}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-00987-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-00987-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-00987-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T08:39:51Z","timestamp":1752136791000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-00987-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,8]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["987"],"URL":"https:\/\/doi.org\/10.1038\/s43856-025-00987-4","relation":{},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,8]]},"assertion":[{"value":"12 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"282"}}